412. Clinical and Pharmacoeconomic Evaluation of Antifungal Prophylaxis With Continuous Micafungin Compared to Posaconazole With Micafungin Bridging in Patients Undergoing Allogeneic Stem Cell Transplantation: A 6-Year Cohort Analysis

BACKGROUND: Patients undergoing allogeneic stem-cell transplantation (aSCT) are at high risk of invasive fungal disease (IFD). Optimization of antifungal prophylaxis strategies may further improve patient outcomes and reduce treatment costs. METHODS: We performed a retrospective single-center pharma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Heimann, Sebastian M, Vehreschild, Maria J G T, Franke, Bernd, Cornely, Oliver, Hamprecht, Axel, Piepenbrock, Ellen, Scheid, Christoph, Vehreschild, Janne
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254699/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.423
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares